High Invasive Melanoma Cells Induce Matrix Metalloproteinase-1 Synthesis in Fibroblasts by Interleukin-1α and Basic Fibroblast Growth Factor-Mediated Mechanisms-Reference-Cited by-同舟云学术

High Invasive Melanoma Cells Induce Matrix Metalloproteinase-1 Synthesis in Fibroblasts by Interleukin-1α and Basic Fibroblast Growth Factor-Mediated Mechanisms

Published:2005-03 Issue:3 Volume:124 Page:638-643
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Löffek Stefanie,Zigrino Paola,Angel Peter,Anwald Birgit,Krieg Thomas,Mauch Cornelia

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference39 articles.

1. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas;Airola;Br J Cancer,1999

2. Interleukin-1—a major pleiotropic cytokine in tumor–host interactions;Apte;Semin Cancer Biol,2002

3. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor;Becker;EMBO J,1989

4. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen;Benbow;J Biol Chem,1999

5. Inflammation and cancer;Coussens;Nature,2002

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dormancy of cutaneous melanoma;Cancer Cell International;2024-02-28

2. The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy;Cytokine & Growth Factor Reviews;2021-12

3. Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis;Current Chemical Biology;2021-04-27

4. CHARACTERISTICS OF THE IMMUNE MICROENVIRONMENT OF THE NORMAL MUCOUS MEMBRANE OF THE PERITUMORAL AREA IS AN ADDITIONAL INDEPENDENT PROGNOSTIC FACTOR IN GASTRIC CANCER;Siberian journal of oncology;2021-03-06

5. Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities;Frontiers in Oncology;2021-02-04